Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/NEN.0000000000000176PMID 25756590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior

  2014cited by this paper
• Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.

  2014influential reference
• Alzheimer disease and cellular mechanisms of memory storage.

  2014cited by this paper
• Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation!

  2014cited by this paper
• Emergent Properties of Microglia

  2014cited by this paper
• Innate immune activation in neurodegenerative disease

  2014cited by this paper
• Proinflammatory cytokines, aging, and age-related diseases.

  2013cited by this paper
• The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease.

  2013cited by this paper
• The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

  2013cited by this paper
• Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model.

  2013cited by this paper
• Microglia actions in Alzheimer’s disease

  2013cited by this paper
• Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

  2013cited by this paper
• Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony.

  2013cited by this paper
• Genetics of Alzheimer's Disease

  2013cited by this paper
• Review: Systemic inflammation and Alzheimer's disease

  2013cited by this paper
• Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease.

  2012cited by this paper
• The Toxicity of Amyloid β Oligomers

  2012cited by this paper
• Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.

  2012influential reference
• Early Stage Drug Treatment That Normalizes Proinflammatory Cytokine Production Attenuates Synaptic Dysfunction in a Mouse Model That Exhibits Age-Dependent Progression of Alzheimer's Disease-Related Pathology

  2012cited by this paper
• Potential Immunotargets for Alzheimer's Disease Treatment Strategies

  2012cited by this paper
• Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study

  2012cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

  2012cited by this paper
• rug pipeline in neurodegeneration based on transgenic mice models of lzheimer ’ s disease

  2012cited by this paper
• Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.

  2012cited by this paper
• Preventing Alzheimer’s Disease

  2012cited by this paper
• Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease

  2012cited by this paper
• Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

  2012cited by this paper
• A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

  2012cited by this paper
• Molecular Mechanisms of Amyloid Oligomers Toxicity

  2012cited by this paper
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cited by this paper
• Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

  2012cited by this paper
• Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.

  2012cited by this paper
• Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?

  2011cited by this paper
• Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease*

  2011cited by this paper
• Role of microglia in CNS inflammation

  2011cited by this paper
• Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy

  2011cited by this paper
• Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology

  2011cited by this paper
• Potent amyloidogenicity and pathogenicity of Aβ43

  2011cited by this paper
• Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.

  2011cited by this paper
• Synaptic Pruning by Microglia Is Necessary for Normal Brain Development

  2011cited by this paper
• Transgenic AD Model Mice, Effects of Potential Anti-AD Treatments on Inflammation, and Pathology

  2011cited by this paper
• History of Innate Immunity in Neurodegenerative Disorders

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Neuroinflammation and ageing: current theories and an overview of the data.

  2011cited by this paper
• Neuropathology of Alzheimer's Disease and its Variants

  2011cited by this paper
• Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.

  2011cited by this paper
• A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

  2010cited by this paper
• Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

  2010cited by this paper
• Inflammation and Alzheimer’s disease

  2010cited by this paper
• Neuropathologic Alterations in Mild Cognitive Impairment: A Review

  2010cited by this paper
• Changing Face of Microglia

  2010cited by this paper
• Neuroinflammation and Cognitive Aging

  2010cited by this paper
• Lipid Alterations in Lipid Rafts from Alzheimer's Disease Human Brain Cortex

  2010cited by this paper
• Amyloid Oligomer Structures and Toxicity~!2009-04-30~!2009-07-07~!2010-01-02~!

  2010cited by this paper
• Contribution of systemic inflammation to chronic neurodegeneration

  2010cited by this paper
• The Aging Human Brain

  2010cited by this paper
• Role of Oxidative Stress in the Progression of Alzheimer's Disease

  2010cited by this paper
• Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy

  2010cited by this paper
• A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

  2010cited by this paper
• Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction.

  2009cited by this paper
• Apollo: a community resource for genome annotation editing

  2009cited by this paper
• Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer’s disease

  2009cited by this paper
• Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

  2009cited by this paper
• Amyloid Oligomer Structures and Toxicity

  2009cited by this paper
• The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?

  2009cited by this paper
• Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease

  2009cited by this paper
• Amyloid β-Protein Assembly and Alzheimer Disease*

  2009cited by this paper
• Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis

  2009cited by this paper
• The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

  2009cited by this paper
• Microglia: biology and pathology

  2009cited by this paper
• Protective effects of NSAIDs on the development of Alzheimer disease

  2008cited by this paper
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

  2008cited by this paper
• Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic

  2008cited by this paper
• Structural Classification of Toxic Amyloid Oligomers*

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2007cited by this paper
• Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease

  2006cited by this paper
• Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia

  2006cited by this paper
• Age and neuroinflammation: a lifetime of psychoneuroimmune consequences.

  2006cited by this paper
• TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue.

  2006cited by this paper
• Microglial senescence: does the brain's immune system have an expiration date?

  2006cited by this paper
• Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.

  2006cited by this paper
• The natural and molecular history of Alzheimer's disease

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

  2006cited by this paper
• Machine Learning Concepts and Tools for Statistical Genomics

  2005cited by this paper
• Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation

  2005cited by this paper
• Independent accumulations of tau and amyloid β-protein in the human entorhinal cortex

  2005influential reference
• limma: Linear Models for Microarray Data

  2005cited by this paper
• Microglia and neuroprotection: implications for Alzheimer's disease.

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004influential reference
• Dystrophic microglia in the aging human brain

  2004cited by this paper
• Rofecoxib

  2004cited by this paper
• Inflammation and the Degenerative Diseases of Aging

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Cytokines and the aging brain - what we don't know might help us.

  2004cited by this paper
• A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation

  2003cited by this paper
• Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria.

  2003cited by this paper

• Bibliometric analysis of neuroinflammation in Alzheimer's Disease: Insights from APP/PS1 mouse model research in the past two decades.

  2026cites this paper
• NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model

  2026cites this paper
• MicroRNA-29a-5p contributes to neuroinflammation through TLR7

  2026cites this paper
• Tau oligomer heterogeneity and associated protein profile in slowly versus rapidly progressive Alzheimer’s disease

  2025cites this paper
• Early branched-chain amino acid reduction delays the onset of cognitive decline in a mouse model of Alzheimer's disease

  2025cites this paper
• Intermittent supplementation with Akkermansia muciniphila and galactooligosaccharides modulates Alzheimer’s disease progression, gut microbiota, and colon short-chain fatty acid profiles in mice

  2025cites this paper
• Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action.

  2025cites this paper
• Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases

  2025cites this paper
• Role of microglia in stroke

  2024cites this paper
• Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice

  2024cites this paper
• Microglia in the aged brain develop a hypoactive molecular phenotype after surgery

  2024cites this paper
• Glyphosate exposure exacerbates neuroinflammation and Alzheimer’s disease-like pathology despite a 6-month recovery period in mice

  2024cites this paper
• TLR4-mediated chronic neuroinflammation has no effect on tangle pathology in a tauopathy mouse model

  2024cites this paper
• Omnidirectional improvement of mitochondrial health in Alzheimer's disease by multi-targeting engineered activated neutrophil exosomes.

  2024cites this paper
• Interactions of the CSF3R polymorphism and early stress on future orientation: evidence for the differential model of stress-related growth

  2024cites this paper
• Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An Update.

  2024cites this paper
• Brain-Penetrant NF-κB and NLRP3 Targeting Nanoligomers are Therapeutic in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD) Human Organoid and Mouse Models

  2024cites this paper
• Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain

  2023cites this paper
• Correlation between Blood Monocytes and CSF Tau in Alzheimer’s Disease: The Effect of Gender and Cognitive Decline

  2023cites this paper
• Early‐life stress and amyloidosis in mice share pathogenic pathways involving synaptic mitochondria and lipid metabolism

  2023cites this paper
• Alzheimer’s genes in microglia: a risk worth investigating

  2023cites this paper
• Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology

  2023cites this paper
• Perinatal S-Adenosylmethionine Supplementation Represses PSEN1 Expression by the Cellular Epigenetic Memory of CpG and Non-CpG Methylation in Adult TgCRD8 Mice

  2023cites this paper
• Pharmacological modulation of autophagy for epilepsy therapy: opportunities and obstacles.

  2023cites this paper
• Early-life stress exposure impacts the hippocampal synaptic proteome in a mouse model of Alzheimer’s disease: age- and pathology-dependent effects on mitochondrial proteins

  2023cites this paper
• YB-1 Protein Prevents Age-Related Decline in Plasma Estradiol in Aging Female 5xFAD Transgenic Mice

  2023cites this paper
• The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Age-dependent impact of early-life stress on glia and synapses Substrates for increased risk for Alzheimer’s disease

  2022cites this paper
• Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease

  2022cites this paper
• Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease

  2022cites this paper
• The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrier

  2022cites this paper
• Two novel mouse models of slow-wave-sleep enhancement in aging and Alzheimer’s disease

  2022cites this paper
• Microglia: Friend and Foe in Tauopathy.

  2022cites this paper
• Glial Cells in Alzheimer's Disease: From Neuropathological Changes to Therapeutic Implications.

  2022cites this paper
• Microglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target

  2022cites this paper
• The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1–42)-Induced Neuroinflammation in Mouse Models of Alzheimer’s Disease

  2021cites this paper
• Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles

  2021cites this paper
• AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway

  2021cites this paper
• Significant Effects of CCR5delta32 Polymorphism on Alzheimer‘S Disease, Neurological Disorders, Cancer, Diabetes and Viral Infection in the Worldwide Population

  2021cites this paper
• Microglial activation and tau propagate jointly across Braak stages

  2021cites this paper
• Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease

  2021cites this paper
• Sodium Houttuyfonate Ameliorates β-amyloid1-42-Induced Memory Impairment and Neuroinflammation through Inhibiting the NLRP3/GSDMD Pathway in Alzheimer's Disease

  2021cites this paper
• Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunction

  2021cites this paper
• Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

  2021cites this paper
• The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

  2021cites this paper
• Cognitive effects of the GSK-3 inhibitor "lithium" in LPS/chronic mild stress rat model of depression: Hippocampal and cortical neuroinflammation and tauopathy.

  2021cites this paper
• DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.

  2020cites this paper
• Regulation of interleukin 6 by a polymorphic CpG within the frontal cortex in Alzheimer's disease.

  2020cites this paper
• Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Single-nucleus RNA sequencing reveals transcriptional changes of hippocampal neurons in APP23 mouse model of Alzheimer’s disease

  2020cites this paper
• Smelling the Dark Proteome: Functional Characterization of PITH Domain-Containing Protein 1 (C1orf128) in Olfactory Metabolism.

  2020cites this paper
• CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain

  2020cites this paper
• Molecular aspects of metallothioneins in dementias

  2020cites this paper
• The neuroprotection of progesterone against Aβ-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes.

  2019cites this paper
• Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects

  2019cites this paper
• Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia.

  2019cites this paper
• Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

  2019cites this paper
• Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice

  2019cites this paper
• Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins

  2019cites this paper
• Exploring the brain tissue proteome of TgCRND8 Alzheimer's Disease model mice under B vitamin deficient diet induced hyperhomocysteinemia by LC-MS top-down platform.

  2019cites this paper
• Glutaminase C Regulates Microglial Activation and Pro-inflammatory Exosome Release: Relevance to the Pathogenesis of Alzheimer’s Disease

  2019cites this paper
• Entanglement of CCR5 and Alzheimer’s Disease

  2019cites this paper
• Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease

  2019cites this paper
• Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

  2019cites this paper
• DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss

  2019cites this paper
• The effects of n-6 polyunsaturated fatty acid deprivation on the inflammatory gene response to lipopolysaccharide in the mouse hippocampus

  2019cites this paper
• The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease

  2018cites this paper
• Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies

  2018cites this paper
• Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging

  2018cites this paper
• Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology

  2018cites this paper
• The involvement of the brain microenvironment in Alzheimer’s Disease

  2018cites this paper
• Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer’s Disease Sequencing Project

  2018cites this paper
• Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice.

  2018cites this paper
• A Meta-Analysis Assessing the Role of Phosphorylated Tau and Amyloid-Beta on Cognitive Decline in a Preclinical Model Of Alzheimer's Disease

  2018cites this paper
• Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD

  2018cites this paper
• Melatonin ameliorates Aβ1‐42‐induced Alzheimer's cognitive deficits in mouse model

  2018cites this paper
• THE PREBIOTIC INULIN BENEFICIALLY MODULATES THE GUT-BRAIN AXIS BY ENHANCING METABOLISM IN AN APOE4 MOUSE MODEL

  2018cites this paper
• Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia

  2018cites this paper
• Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis

  2018cites this paper
• The role of dialysis in the pathogenesis and treatment of dementia.

  2018cites this paper
• Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease

  2017cites this paper
• Alpha-Lipoic Acid Downregulates IL-1β and IL-6 by DNA Hypermethylation in SK-N-BE Neuroblastoma Cells

  2017cites this paper
• Diversity of astroglial responses across human neurodegenerative disorders and brain aging

  2017cites this paper
• Innate immunity in Alzheimer’s disease: the relevance of animal models?

  2017influential citation
• Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy

  2017cites this paper
• DNA methylation alterations in Alzheimer’s disease

  2017cites this paper
• Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.

  2017cites this paper
• Alpha-Lipoic Acid Downregulates IL-1 β and IL-6 by DNA Hypermethylation in SK-NBE Neuroblastoma Cells

  2017cites this paper
• Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms

  2017cites this paper
• Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice

  2017cites this paper
• Sisyphus in Neverland

  2017cites this paper
• Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology

  2017cites this paper
• EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease[S]

  2017cites this paper
• Trans‐caryophyllene inhibits amyloid &bgr; (A&bgr;) oligomer‐induced neuroinflammation in BV‐2 microglial cells

  2017cites this paper
• DNA Methylation Profiles of Selected Pro-Inflammatory Cytokines in Alzheimer Disease

  2017cites this paper
• YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

  2017cites this paper
• N-3 Polyunsaturated Fatty Acids and Neuroinflammation in Alzheimer's Disease

  2017cites this paper
• Daño oxidativo y regulación redox en el envejecimiento cerebral: vulnerabilidad regional

  2017cites this paper
• Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

  2017cites this paper